title: Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator.
abstract: Angiogenesis is induced by soluble factors such as vascular endothelial growth factor (VEGF) released from tumor cells in hypoxia. It enhances solid tumor growth and provides an ability to establish metastasis at peripheral sites by tumor cell migration. Thymosin beta-4 (TB4) is an actin-sequestering protein to control cytoskeletal reorganization. Here, we investigated whether angiogenesis and tumor metastasis are dependent on hypoxia conditioning-induced TB4 expression in B16F10 melanoma cells. TB4 expression in B16F10 cells was increased by hypoxia conditioning in a time-dependent manner. In addition, we found an increase of angiogenesis and HIF-1α expression in TB4-transgenic (Tg) mice as compared to wildtype mice. When wound healing assay was used to assess in vitro tumor cell migration, hypoxia conditioning for 1 h enhanced B16F10 cell migration. When TB4 expression in B16F10 cells was inhibited by the infection with small hairpin (sh) RNA of TB4 cloned in lentiviral vector, tumor cell migration was retarded. In addition, hypoxia conditioning-induced tumor cell migration was reduced by the infection of lentiviral shRNA of TB4. HIF-1α stabilization and the expression of VEGF isoform 165 and 121 in hypoxia were also reduced by the infection of lentiviral shRNA of TB4 in B16F10 cells. We also found an increase of tumor growth and lung metastasis count in TB4-Tg mice as compared to wildtype mice. Collectively, hypoxia conditioning induced tumor cell migration by TB4 expression-dependent HIF-1α stabilization. It suggests that TB4 could be a hypoxia responsive regulator to control tumor cell migration in angiogenesis and tumor metastasis.
authors.affiliation: Department of Bioscience and Biotechnology, Sejong University, Seoul, Korea. eunyimoon@sejong.ac.kr
authors.forename: Eun-Yi
authors.initials: EY
authors.lastname: Moon
authors.forename: Yun-Sun
authors.initials: YS
authors.lastname: Im
authors.forename: Yun-Kyoung
authors.initials: YK
authors.lastname: Ryu
authors.forename: Joo-Hyun
authors.initials: JH
authors.lastname: Kang
mesh_terms: D000818:Animals; D015687:Cell Hypoxia / Q000502:physiology*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary; D008546:Melanoma, Experimental / Q000098:blood supply / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013947:Thymosin / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D000099201:Thymosin beta(4)
chemical_list: D013947:Thymosin; D000099201:Thymosin beta(4)
references.citation: Cancer Res. 2001 Apr 1;61(7):3206-11
references.pmid: 11306510
references.citation: Cancer Metastasis Rev. 2000;19(1-2):59-65
references.pmid: 11191064
references.citation: J Cell Sci. 2003 Jun 1;116(Pt 11):2247-60
references.pmid: 12697836
references.citation: Cancer Lett. 2007 Dec 8;258(1):63-9
references.pmid: 17919812
references.citation: J Vasc Res. 2006;43(6):511-21
references.pmid: 17008771
references.citation: J Natl Cancer Inst. 2003 Nov 19;95(22):1674-80
references.pmid: 14625258
references.citation: Exp Cell Res. 2006 May 15;312(9):1651-7
references.pmid: 16515784
references.citation: J Cell Physiol. 2003 Jan;194(1):30-44
references.pmid: 12447987
references.citation: Cancer Lett. 2008 Jun 8;264(1):29-35
references.pmid: 18272284
references.citation: Int J Biochem Cell Biol. 2001 Mar;33(3):205-20
references.pmid: 11311852
references.citation: IUBMB Life. 2001 Jul;52(1-2):49-53
references.pmid: 11795593
references.citation: J Biol Chem. 2004 May 28;279(22):23637-45
references.pmid: 15039431
references.citation: Growth Factors. 1995;12(4):289-301
references.pmid: 8930020
references.citation: Ann N Y Acad Sci. 2002 Nov;973:448-53
references.pmid: 12485909
references.citation: J Hepatol. 1999 Jul;31(1):123-32
references.pmid: 10424292
references.citation: Bioessays. 1994 Jul;16(7):473-9
references.pmid: 7945275
references.citation: Oncogene. 2007 Apr 26;26(19):2781-90
references.pmid: 17072345
references.citation: Science. 2001 May 25;292(5521):1502-6
references.pmid: 11379633
references.citation: Annu Rev Cell Biol. 1986;2:337-65
references.pmid: 3548771
references.citation: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
references.pmid: 7539918
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7987-92
references.pmid: 9653127
references.citation: J Virol. 1998 Nov;72(11):8463-71
references.pmid: 9765382
references.citation: J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
references.pmid: 1688381
references.citation: J Natl Cancer Inst. 2003 Nov 19;95(22):1646-7
references.pmid: 14625249
references.citation: Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1095-100
references.pmid: 15037574
references.citation: FEBS Lett. 2000 Feb 18;468(1):53-8
references.pmid: 10683440
references.citation: Cell. 2004 May 28;117(5):611-23
references.pmid: 15163409
references.citation: Endocr Rev. 1992 Feb;13(1):18-32
references.pmid: 1372863
references.citation: Curr Opin Cell Biol. 2000 Feb;12(1):104-12
references.pmid: 10679366
references.citation: Nat Genet. 2000 Jun;25(2):217-22
references.pmid: 10835641
references.citation: Cancer Lett. 2009 Jun 28;279(1):108-17
references.pmid: 19231068
references.citation: Mol Pharmacol. 2006 Nov;70(5):1469-80
references.pmid: 16887934
references.citation: Ophthalmic Res. 2009;41(1):36-43
references.pmid: 18854659
references.citation: Mol Endocrinol. 1991 Dec;5(12):1806-14
references.pmid: 1791831